NCT02315599View on ClinicalTrials.gov

Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials

Enrolling by invitationOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

December 23, 2014

Primary Completion Date

April 1, 2035

Study Completion Date

August 1, 2050

Conditions

Pediatric CancersHematologic MalignanciesSolid Tumors

Interventions

DRUG

anti-CD19 CAR

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH